Danaher Co. (NYSE:DHR) Shares Sold by Principal Financial Group Inc.

Principal Financial Group Inc. trimmed its holdings in shares of Danaher Co. (NYSE:DHR) by 1.9% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,056,976 shares of the conglomerate’s stock after selling 58,911 shares during the period. Principal Financial Group Inc. owned approximately 0.41% of Danaher worth $849,901,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. nVerses Capital LLC acquired a new stake in Danaher in the second quarter worth approximately $25,000. CarsonAllaria Wealth Management Ltd. bought a new stake in Danaher in the second quarter worth about $25,000. MFA Wealth Advisors LLC acquired a new stake in Danaher in the 2nd quarter valued at about $51,000. Financial Connections Group Inc. bought a new position in shares of Danaher during the 2nd quarter valued at about $51,000. Finally, Western Pacific Wealth Management LP acquired a new position in shares of Danaher in the 1st quarter worth approximately $55,000. 79.05% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of research reports. Stephens restated an “overweight” rating and set a $315.00 target price on shares of Danaher in a report on Wednesday, October 23rd. Barclays reduced their price objective on Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 23rd. StockNews.com raised Danaher from a “hold” rating to a “buy” rating in a research report on Wednesday. Raymond James decreased their price target on Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a research report on Wednesday, October 23rd. Finally, Robert W. Baird dropped their price target on Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $287.16.

Danaher Trading Down 0.9 %

NYSE DHR opened at $247.81 on Thursday. The company has a market capitalization of $178.99 billion, a PE ratio of 47.29, a price-to-earnings-growth ratio of 4.55 and a beta of 0.85. Danaher Co. has a 1-year low of $192.35 and a 1-year high of $281.70. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The firm’s fifty day simple moving average is $265.79 and its 200-day simple moving average is $260.75.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The company had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business’s quarterly revenue was up 3.1% on a year-over-year basis. During the same period last year, the business earned $2.02 EPS. As a group, sell-side analysts anticipate that Danaher Co. will post 7.51 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were given a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.44%. The ex-dividend date was Friday, September 27th. Danaher’s dividend payout ratio is 20.61%.

Insider Transactions at Danaher

In related news, SVP Georgeann Couchara sold 952 shares of the company’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the sale, the senior vice president now directly owns 4,212 shares in the company, valued at approximately $1,130,374.44. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 10.90% of the stock is currently owned by company insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.